Conference Reports for NATAP

65th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 7-11 2014 Back

Safety and Efficacy of New DAA---based Therapy for Hepatitis C Post---Transplant: Interval Results from the HCV---TARGET Longitudinal, Observational Study       Reported by Jules Levin AASLD 2014 Nov 7-11 Boston   Robert Brown et al